|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/30 | |
| A61K 38/29 | |||
| A61K 47/22 | |||
| A61K 47/20 | |||
| A61K 47/10 | |||
| A61K 38/48 | |||
| A61K 38/25 | |||
| A61K 38/16 | |||
| A61K 38/02 | |||
| A61K 38/18 | |||
| A61K 38/17 | |||
| A61K 38/09 | |||
| A61K 9/00 | |||
| A61K 38/28 | |||
| A61K 38/26 | |||
| A61K 38/22 | |||
| A61K 47/18 | |||
| A61K 47/14 | |||
| A61K 47/12 |
| (11) | Patento numeris | 3225235 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17151475.5 |
| Europos patento paraiškos padavimo data | 2012-03-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161451568 P | 2011-03-10 | US | |
| 201161478692 P | 2011-04-25 | US | |
| 201161553388 P | 2011-10-31 | US |
| (72) |
KINZELL, John, US
PRESTRELSKI, Steven, US
|
| (73) |
Xeris Pharmaceuticals, Inc.,
180 N. LaSalle Street, Suite 1600, Chicago, IL 60601,
US
|
| (54) | STABLE PEPTIDE FORMULATIONS FOR PARENTERAL INJECTION |
| STABLE PEPTIDE FORMULATIONS FOR PARENTERAL INJECTION |